Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Enbrel warning related to infections issued by FDA and Immunex

May 13, 1999

Second COX-2 inhibitor reaches the market

May 13, 1999

Antagonists of MIP-1alpha/RANTES receptor disclosed by Takeda

May 12, 1999

Searle reports new COX-2 inhibitor series bearing a sulfonamide moiety

May 11, 1999

Almirall Prodesfarma patents new series of selective COX-2 inhibitors

May 11, 1999

M-5011 compares favorably to indomethacin in model of gouty arthritis

May 7, 1999

Novel naturally occurring proteasome inhibitor TMC-95A discovered at Tanabe Seiyaku

May 7, 1999

Potent and selective COX-2 inhibitors in the Glaxo Wellcome pipeline

May 4, 1999

Celebrex launched in Canada for arthritis

April 30, 1999

Positive results achieved in Alexion's phase I/II study of 5G1.1 in RA

April 27, 1999

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...